January 26, 2018 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

QIAGEN receives FDA approval to expand use of EGFR test in lung cancer

Germantown, Maryland, and Hilden, Germany, January 18, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved a PMA supplement extending the indications for use of QIAGEN’s therascreen® EGFR RGQ PCR Kit as a companion diagnostic to guide the use of Boehringer Ingelheim’s... Read more

January 23, 2018 Acad, Gov/Utilities PR/Corporate

QIAGEN receives FDA clearance for first-ever JAK2 test for use in diagnosis of additional myeloproliferative neoplasms

Hilden, Germany, and Germantown, Maryland, January 23, 2018 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has received clearance for its ipsogen JAK2 RGQ PCR Kit (ipsogen JAK2 assay) from the U.S. Food and Drug Administration (FDA) for additional use in the diagnosis of all myeloproliferative neoplasms (MPNs), which are a... Read more

January 23, 2018 Cell Analysis Tools PR/Corporate

Cell Microsystems continues momentum with $1.5M NIH grant for innovative single-cell RNA-Seq platform

Company awarded second patent for CellRaft™ technology January 23, 2018  RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced today it has been awarded a $1.5 million grant under the National Institutes of Health (NIH) SBIR program. The proposed system integrates Cell... Read more

January 22, 2018 Chromatography Lab Top-10 PR/Corporate

Agilent Named Company of the Year by Instrument Business Outlook

Agilent Named Company of the Year by Instrument Business Outlook Industry Newsletter Cites Technology Development, Operational and Financial Performance SANTA CLARA, Calif., Jan. 22, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it has been selected as 2017 Company of the Year by Instrument Business Outlook (IBO). IBO is a respected industry newsletter that... Read more

January 18, 2018 Lab Top-10 PR/Corporate

Dow R. Wilson to Join Agilent’s Board of Directors

CEO of Varian Medical Systems brings deep knowledge of the healthcare industry SANTA CLARA, Calif.–(BUSINESS WIRE)–Jan. 18, 2018– Agilent Technologies, Inc. (NYSE: A) today announced that Dow R. Wilson, CEO of Varian Medical Systems, Inc., has been elected to its board of directors, effective March 20, 2018. Since 2012 Wilson has been CEO of Varian... Read more

January 17, 2018 PR/Corporate Uncategorized

BD Announces Webcast of Annual Meeting of Shareholders

FRANKLIN LAKES, N.J., Jan. 17, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 23, 2018, at 1 p.m. (ET). The webcast can be accessed from the BD corporate website at http://www.bd.com/investors/ and... Read more